Cerebral Infarction as a Rare Adverse Event of Immune Checkpoint Inhibitors in Patients With Head and Neck Squamous Cell Carcinoma: A Case Series

Immune checkpoint inhibitors (ICIs) are a novel treatment option for treating head and neck squamous cell carcinoma (HNSCC). Among the immune-related adverse effects, cerebral infarction (CI) is a rare but fatal complication, and it has been reported in various cancers, except HNSCC. Herein, we desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Takahiro, Kumai, Takumi, Ohara, Kenzo, Takahara, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658212/
https://www.ncbi.nlm.nih.gov/pubmed/38021593
http://dx.doi.org/10.7759/cureus.47406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658212/
https://www.ncbi.nlm.nih.gov/pubmed/38021593
http://dx.doi.org/10.7759/cureus.47406

Ejemplares similares